Piramal Pharma Limited Financial Flexibility Index
Piramal Pharma Limited financial flexibility index. Piramal Pharma Limited (PPLPHARMA) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of Rs13.23 Billion (operating CF Rs8.90 Billion minus capex Rs4.33 Billion) represents 0% of total liabilities (Rs81.16 Billion). Explore Piramal Pharma Limited capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Piramal Pharma Limited (2021–2026)
Financial flexibility index of Piramal Pharma Limited from 2021 to 2026. Historical Financial Flexibility Index trend for Piramal Pharma Limited across 6 annual periods. Check total reinvestment intensity of Piramal Pharma Limited to assess the company's total reinvestment commitment from operating cash flow.
Piramal Pharma Limited Financial Flexibility Index by Year (2021–2026)
Piramal Pharma Limited financial flexibility index by year from 2021 to 2026. Year-by-year free cash flow to debt coverage for Piramal Pharma Limited. For the full cash flow conversion analysis, see Piramal Pharma Limited cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.23x | Rs22.90 Billion | Rs14.00 Billion | Rs98.02 Billion | ▲ +13.3% |
| 2025 | 0.21x | Rs15.57 Billion | Rs8.92 Billion | Rs75.52 Billion | ▼ -11.1% |
| 2024 | 0.23x | Rs17.17 Billion | Rs10.05 Billion | Rs74.00 Billion | ▲ +24.1% |
| 2023 | 0.19x | Rs14.49 Billion | Rs4.84 Billion | Rs77.49 Billion | ▲ +150.3% |
| 2022 | 0.07x | Rs4.56 Billion | Rs2.55 Billion | Rs61.00 Billion | ▲ +33.3% |
| 2021 | 0.06x | Rs928.30 Million | Rs347.20 Million | Rs16.56 Billion | — |